Medical device recalls Moderate risk

BioCheck, Inc. recalls T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use is For the qua…

Recall date
October 14, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0214-2022
FDA classification
Class II
Brand / firm
BioCheck, Inc.
Sold / distributed
US Distribution to states of: MI, FL, NJ, OH, CA; and OUS (foreign) distribution to countries of: Spain, Taiwan and Nigeria

Why it was recalled

Immunoassay TEST Kit do not meet product shelf-life standards resulting in failed controls.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use is For the quantitative determination of total thyroxine (T4) concentration in human serum. The test is useful in the diagnosis and treatment of thyroid disorders.

Get recall alerts

Free email alert whenever BioCheck, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: BioCheck, Inc.